SE466449B - Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition - Google Patents

Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition

Info

Publication number
SE466449B
SE466449B SE8801964A SE8801964A SE466449B SE 466449 B SE466449 B SE 466449B SE 8801964 A SE8801964 A SE 8801964A SE 8801964 A SE8801964 A SE 8801964A SE 466449 B SE466449 B SE 466449B
Authority
SE
Sweden
Prior art keywords
formula
compound
optionally substituted
therapeutic composition
cycloalkyl
Prior art date
Application number
SE8801964A
Other languages
English (en)
Swedish (sv)
Other versions
SE8801964L (sv
SE8801964D0 (sv
Inventor
J-J Godfroid
F Heymans
P Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of SE8801964D0 publication Critical patent/SE8801964D0/xx
Publication of SE8801964L publication Critical patent/SE8801964L/xx
Publication of SE466449B publication Critical patent/SE466449B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8801964A 1987-05-29 1988-05-26 Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition SE466449B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878712693A GB8712693D0 (en) 1987-05-29 1987-05-29 Tetrahydrofurans etc

Publications (3)

Publication Number Publication Date
SE8801964D0 SE8801964D0 (sv) 1988-05-26
SE8801964L SE8801964L (sv) 1988-11-30
SE466449B true SE466449B (sv) 1992-02-17

Family

ID=10618139

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8801964A SE466449B (sv) 1987-05-29 1988-05-26 Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition

Country Status (32)

Country Link
US (1) US5017588A (ja)
JP (1) JPH0631228B2 (ja)
KR (1) KR960005152B1 (ja)
AR (1) AR243885A1 (ja)
AT (1) AT395715B (ja)
AU (1) AU610789B2 (ja)
BE (1) BE1002146A3 (ja)
CA (1) CA1317959C (ja)
CH (1) CH674985A5 (ja)
DE (1) DE3818106A1 (ja)
DK (1) DK167532B1 (ja)
ES (1) ES2009924A6 (ja)
FI (1) FI89353C (ja)
FR (2) FR2615735B1 (ja)
GB (2) GB8712693D0 (ja)
GR (1) GR1000147B (ja)
HK (1) HK101790A (ja)
IE (1) IE61341B1 (ja)
IN (1) IN168799B (ja)
IT (1) IT1219698B (ja)
LU (1) LU87229A1 (ja)
MA (1) MA21289A1 (ja)
MY (1) MY103289A (ja)
NL (1) NL192203C (ja)
NO (1) NO170086C (ja)
NZ (1) NZ224775A (ja)
OA (1) OA08878A (ja)
PT (1) PT87585B (ja)
SE (1) SE466449B (ja)
SG (1) SG93790G (ja)
TN (1) TNSN88049A1 (ja)
ZA (1) ZA883731B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc
ES2010568A6 (es) * 1988-08-04 1989-11-16 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 2,5-disustituidos de tetrahidrofurano.
ES2013834A6 (es) * 1989-01-30 1990-06-01 Uriach & Cia Sa J Procedimiento para la obtencion de derivados 4-sustituidos de 2-alcoxitetrahidrofurano.
US5118708A (en) * 1989-06-23 1992-06-02 Norwich Eaton Pharmaceuticals, Inc. Use of 5-phenyl-2-furan esters, amides and ketones as neuroprotective agents
US20110097352A9 (en) * 1992-01-29 2011-04-28 Pharmexa Inc. Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
KR100326276B1 (ko) * 1999-12-14 2002-03-08 정명식 테트라하이드로푸란 유도체, 이의 제조방법 및 이를포함하는 항진균제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1088880A (en) * 1964-11-18 1967-10-25 Vantorex Ltd ª‡-cycloalkyleneimino-substituted esters
GB8701727D0 (en) * 1987-01-27 1987-03-04 Scras Tetrahydrofuran derivatives
GB8712694D0 (en) * 1987-05-29 1987-07-01 Scras Tetrahydrofurans etc

Also Published As

Publication number Publication date
NL192203B (nl) 1996-11-01
NL8801315A (nl) 1988-12-16
DK291088A (da) 1988-11-30
IE881599L (en) 1988-11-29
GB8812488D0 (en) 1988-06-29
DK167532B1 (da) 1993-11-15
CA1317959C (en) 1993-05-18
FR2615854A1 (fr) 1988-12-02
NO882335L (no) 1988-11-30
SE8801964L (sv) 1988-11-30
AU1672288A (en) 1988-12-01
NO170086C (no) 1992-09-09
GR880100342A (en) 1989-02-23
FR2615854B1 (fr) 1990-12-28
FR2615735B1 (fr) 1991-01-11
FR2615735A1 (fr) 1988-12-02
IT8820773A0 (it) 1988-05-27
IN168799B (ja) 1991-06-08
ES2009924A6 (es) 1989-10-16
JPS649988A (en) 1989-01-13
NO882335D0 (no) 1988-05-27
IT1219698B (it) 1990-05-24
US5017588A (en) 1991-05-21
FI89353C (fi) 1993-09-27
GB8712693D0 (en) 1987-07-01
AU610789B2 (en) 1991-05-23
GR1000147B (el) 1991-09-27
ZA883731B (en) 1989-02-22
SG93790G (en) 1991-01-18
GB2205100A (en) 1988-11-30
DK291088D0 (da) 1988-05-27
NL192203C (nl) 1997-03-04
TNSN88049A1 (fr) 1990-07-10
FI882475A0 (fi) 1988-05-26
LU87229A1 (fr) 1988-12-13
SE8801964D0 (sv) 1988-05-26
PT87585A (pt) 1989-05-31
BE1002146A3 (fr) 1990-07-31
KR960005152B1 (ko) 1996-04-22
FI89353B (fi) 1993-06-15
OA08878A (fr) 1989-10-31
NO170086B (no) 1992-06-01
AR243885A1 (es) 1993-09-30
HK101790A (en) 1990-12-14
IE61341B1 (en) 1994-11-02
KR880013928A (ko) 1988-12-22
ATA140788A (de) 1992-07-15
GB2205100B (en) 1990-08-15
PT87585B (pt) 1992-09-30
DE3818106C2 (ja) 1993-07-01
CH674985A5 (ja) 1990-08-15
JPH0631228B2 (ja) 1994-04-27
AT395715B (de) 1993-02-25
NZ224775A (en) 1990-01-29
MY103289A (en) 1993-05-29
MA21289A1 (fr) 1988-12-31
FI882475A (fi) 1988-11-30
DE3818106A1 (de) 1988-12-15

Similar Documents

Publication Publication Date Title
KR19990028709A (ko) 살진균 피리미디논
SK48799A3 (en) New heterocyclylmethyl-substituted pyrazol derivates and their use for treating cardiovascular diseases
DE3409431A1 (de) Cephalosporinderivate und verfahren zu ihrer herstellung
SE466449B (sv) Nya 5-(w-ammoniumacyloximetylen)tetrahydrofuraner och -tetra-hydrotiofener, foerfarande foer framstaellning av dessa och en terapeutisk komposition
AU2020333565A1 (en) Method for preparing drug toxin PNU-159682 of antibody drug conjugate, and intermediate therein
US3875146A (en) Process to prepare intermediates for the preparation of cephalosporins and penicillins
CS262417B2 (en) Process for preparing new 1h,3h-pyrrolo/1,2-c/-thiazoles
EP0139270A2 (en) Thiatriazine dioxides and pharmaceutical compositions containing them
RU2098420C1 (ru) Соединения цефалоспорина, их фармацевтически приемлемые нетоксичные соли, физиологически гидролизуемые сложные эфиры, изомеры, имеющие е-конфигурацию двойной связи в пропенильной группе, син-изомеры и оптические изомеры и способ их получения
NL192573C (nl) 2,5-Digesubstitueerde tetrahydrofuran- of tetrahydrothiofeenverbindingen met werking tegen de bloedplaatjesactiverende factor en farmaceutisch preparaat dat deze verbindingen bevat.
JP2002512603A (ja) 医薬化合物の製造方法
JP2934809B2 (ja) 新規なセファロスポリン系抗生剤およびその製造方法
CN109400608B (zh) 二氮杂螺[4，5]癸烷酒石酸类衍生物制备和应用
JPH01132582A (ja) テトラヒドロフランの２，４−二置換誘導体
FR2531711A1 (fr) Nouveaux derives de la cephalosporine, leur preparation et les medicaments qui les contiennent
CS248746B2 (en) Production method of the 6-(subst.)methylenpenicilan acids
EP0280240B1 (en) Cephalosporin derivatives, process for their preparation and antibacterial agents
HU211844A9 (en) 4-oxo-azetidine-2-sulfonic acids and their salts, processes for the preparation thereof and their use
CA1050010A (en) Process for preparing-3-methyl-4-(5-tetrazolyl)-a3-cephem compounds
KR0177900B1 (ko) 신규한 세팔로스포린계 항생제
SU1160936A3 (ru) Способ получени 3-тиовинилцефалоспоринов
KR100377136B1 (ko) 경구투여가능한 신규 세팔로스포린계 항생제
JPH0544468B2 (ja)
KR0135374B1 (ko) 신규 세팔로스포린계 항생제 및 이의 제조방법
EP0390099B1 (de) Polare Cephalosporinderivate und Verfahren zu ihrer Herstellung

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8801964-1

Format of ref document f/p: F

NUG Patent has lapsed